VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group study JCOG9801

Journal of Clinical Oncology

Volumn 25, Issue 34, 2007, Pages 5458-5464

  Tsukasaki, Kunihiro ^a   Utsunomiya, Atae ^a   Fukuda, Haruhiko ^a   Shibata, Taro ^a   Fukushima, Takuya ^a   Takatsuka, Yoshifusa ^a   Ikeda, Shuichi ^a   Masuda, Masato ^a   Nagoshi, Haruhisa ^a   Ueda, Ryuzo ^a   Tamura, Kazuo ^a   Sano, Masayuki ^a   Momita, Saburo ^a   Yamaguchi, Kazunari ^a   Kawano, Fumio ^a   Hanada, Shuichi ^a   Tobinai, Kensei ^a   Shimoyama, Masanori ^a   Hotta, Tomomitsu ^a   Tomonaga, Masao ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; RANIMUSTINE; VINCRISTINE; VINDESINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOPENIA; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; DYSPNEA; FEMALE; HUMAN; HYPERGLYCEMIA; HYPOKALEMIA; HYPONATREMIA; INFECTION; INTERSTITIAL PNEUMONIA; JAPAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; MYELODYSPLASTIC SYNDROME; NEUROPATHY; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STOMATITIS; T CELL LEUKEMIA; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; NITROSOUREA COMPOUNDS; PREDNISONE; SURVIVAL RATE; VINCRISTINE;

EID: 36849051298     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.9958     Document Type: Article

References (26)

1. Uchiyama T, Yodoi J, Sagawa K, et al: Adult T-cell leukemia: Clinical and hematologic features of 16 cases. Blood 50:481-492, 1977
2. Poiesz BJ, Ruscetti FW, Gazdar AF, et al: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A 77:7415-7419, 1980
3. Yoshida M, Miyoshi I, Hinuma Y: Isolation and characterization of retrovirus from cell lines of human adult T cell leukemia and its implication in the disease. Proc Natl Acad Sci U S A 79:2031-2035, 1982
4. Shimoyama M: Diagnostic criteria and classification of clinical subtypes of adult T- cell leukaemia-lymphoma: A report from the Lymphoma Study Group (1984-87). Br J Haematol 79:428-437, 1991
5. Pawson R, Mufti GJ, Pagliuca A: Management of adult T-cell leukaemia/lymphoma. Br J Haematol 100:453-458, 1998
6. Tobinai K, Watanabe T: Adult T-cell leukemia-lymphoma, in Abeloff MD, Armitage JO, Niederhuber JE, et al (eds): Clinical Oncology (ed 3). Philadelphia, PA, Elsevier Churchill Livingstone, 2004, pp 3109-3130
7. Shimoyama M: Chemotherapy of ATL, in Takatsuki K (ed): Adult T-Cell Leukemia. Oxford, United Kingdom, Oxford University Press, 1994, pp 221-237
8. A predictive model for aggressive non-Hodgkin's lymphoma: The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987-994, 1993
9. Gallamini A, Stelitano C, Calvi R, et al: Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 103:2474-2479, 2004
10. Lymphoma Study Group: Major prognostic factors of patients with adult T-cell leukemia-lymphoma: A cooperative study - Lymphoma Study Group (1984-1987). Leuk Res 15:81-90, 1991
11. Shimoyama M, Ota K, Kikuchi M, et al: Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M. J Clin Oncol 6:128-141, 1988
12. Tobinai K, Shimoyama M, Minato K, et al: Japan Clinical Oncology Group phase II trial of second-generation "LSG4 protocol" in aggressive T- and B-lymphoma: A new predictive model for T-and B-lymphoma. Proc Am Soc Clin Oncol 13:378, 1994 (abstr)
13. Tobinai K, Shimoyama M, Inoue S, et al: Phase I study of YK-176 (2′-deoxycoformycin) in patients with adult T-cell leukemia-lymphoma. Jpn J Clin Oncol 22:164-171, 1992
14. Tsukasaki K, Tobinai K, Shimoyama M, et al: Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109). Int J Hematol 77:164-170, 2003
15. Yamada Y, Tomonaga M, Fukuda H, et al: A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study 9303. Br J Haematol 113:375-382, 2001
16. Tsukasaki K, Ikeda S, Murata K, et al: Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leuk Res 17:157-166, 1993
17. Kuwazuru Y, Hanada S, Furukawa T, et al: Expression of p-glycoprotein in adult T-cell leukemia cells. Blood 76:2065-2071, 1990
18. Itoh K, Ohtsu T, Fukuda H, et al: Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505. Ann Oncol 13:1329-1330, 2002
19. Tobinai K, Kohno A, Shimada Y, et al: Toxicity grading criteria of the Japan Clinical Oncology Group: The Clinical Trial Review Committee of the Japan Clinical Oncology Group. Jpn J Clin Oncol 23:250-257, 1993
20. Lan KKG, DeMets DL: Discrete sequential boundaries for clinical trials. Biometrika 70:659-663, 1983
21. Taguchi H, Kinoshita KI, Takatsuki K, et al: An intensive chemotherapy of adult T-cell leukemia/ lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. J Acquir Immune Defic Syndr Hum Retrovirol 12:182-186, 1996
22. Gill PS, Harrington W Jr, Kaplan MH, et al: Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alpha and zidovudine. N Engl J Med 332:1744-1748, 1995
23. Tobinai K, Kobayashi Y, Shimoyama M: Interferon alpha and zidovudine in adult T-cell leukemialymphoma: Lymphoma Study Group of the Japan Clinical Oncology Group. N Engl J Med 333:1285, 1995
24. Pfreundschuh M, Trumper L, Kloess M, et al: Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL. Blood 104:634-641, 2004
25. Hotta T, Shimakura Y, Ishizuka N, et al: Randomized phase III study of standard CHOP (SCHOP) versus biweekly CHOP (Bi-CHOP) in aggressive non-Hodgkin's lymphoma (NHL): Japan Clinical Oncology Group study, JCOG9809. Proc Am Soc Clin Oncol 22:565, 2003 (abstr 2271)
26. Fukushima T, Miyazaki Y, Honda S, et al: Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 19:829-834, 2005